2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315

Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?

Ahmed, A., Jorna, T., & Bhandari, S. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000447068 · Cited by 11,782

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

(2002) · The Lancet · doi:10.1016/s0140-6736(02)11911-8 · Cited by 10,266

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

(1998) · The Lancet · doi:10.1016/s0140-6736(98)07037-8 · Cited by 8,247

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629

Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia

Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607141 · Cited by 6,900

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults

Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

Cholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

Wiviott, S. D., Raz, I., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., Silverman, M. G., Zelniker, T. A., Kuder, J. F., Murphy, S. A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812389 · Cited by 6,382

A Randomized Trial of Intensive versus Standard Blood-Pressure Control

The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325

A Clinical Trial of the Effects of Dietary Patterns on Blood Pressure

Appel, L. J., Moore, T. J., Obarzanek, E., Vollmer, W. M., Svetkey, L. P., Sacks, F. M., Bray, G. A., Vogt, T. M., Cutler, J. A., Windhauser, M. M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704173361601 · Cited by 5,981

Effects on Blood Pressure of Reduced Dietary Sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet

Sacks, F. M., Svetkey, L. P., Vollmer, W. M., Appel, L. J., Bray, G. A., Harsha, D., Obarzanek, E., Conlin, P. R., Miller, E. R., Simons-Morton, D. G., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440101 · Cited by 5,638

Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels: Results of AFCAPS/TexCAPS

Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236

2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk

Goff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D’Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D., O’Donnell, C. J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.005 · Cited by 4,945

Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association’s Strategic Impact Goal Through 2020 and Beyond

Lloyd-Jones, D. M., Hong, Y., Labarthe, D., Mozaffarian, D., Appel, L. J., Van Horn, L., Greenlund, K., Daniels, S., Nichol, G., Tomaselli, G. F., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.192703 · Cited by 4,750

Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach

Hebert, L. A., Parikh, S. M., Prosek, J. M., Nádasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,392

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

(1998) · PubMed · Cited by 4,290

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

Colhoun, H. M., Betteridge, D. J., Durrington, P. N., Hitman, G. A., W Neil, H. A., Livingstone, S. J., Thomason, M. J., Mackness, M. I., Charlton-Menys, V., & Fuller, J. H. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16895-5 · Cited by 3,755

Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis

Ettehad, D., Emdin, C. A., Kiran, A., Anderson, S. G., Callender, T., Emberson, J., Chalmers, J., Rodgers, A., & Rahimi, K. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01225-8 · Cited by 3,755

Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts

Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1800389 · Cited by 3,616

Effects of intensive blood-pressure control in type 2 diabetes mellitus

(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001286 · Cited by 3,598

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

(2003) · The Lancet · doi:10.1016/s0140-6736(03)13636-7 · Cited by 2,876

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

Collaborators, C. T. T. (. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60367-5 · Cited by 2,833

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

Law, M. R., Morris, J. K., & Wald, N. J. (2009) · BMJ · doi:10.1136/bmj.b1665 · Cited by 2,775

Sedentary Time and Its Association With Risk for Disease Incidence, Mortality, and Hospitalization in Adults: A Systematic Review and Meta-analysis

Biswas, A., Oh, P. I., Faulkner, G. E., Bajaj, R. R., Silver, M. A., Mitchell, M. S., & Alter, D. A. (2015) · Annals of Internal Medicine · doi:10.7326/m14-1651 · Cited by 2,726

Does physical activity attenuate, or even eliminate, the detrimental association of sitting time with mortality? A harmonised meta-analysis of data from more than 1 million men and women

Ekelund, U., Steene-Johannessen, J., Brown, W. J., Fagerland, M. W., Owen, N., Powell, K. E., Bauman, A., & Lee, I.-M. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30370-1 · Cited by 2,648

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

Baigent, C., Landray, M. J., Reith, C., Emberson, J., Wheeler, D. C., Tomson, C., Wanner, C., Krane, V., Cass, A., Craig, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60739-3 · Cited by 2,479

The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease

Klahr, S., Levey, A. S., Beck, G. J., Caggiula, A. W., Hunsicker, L., Kusek, J. W., & Striker, G. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403313301301 · Cited by 2,328

Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review

Mozaffarian, D. (2016) · Circulation · doi:10.1161/circulationaha.115.018585 · Cited by 2,216

Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney Disease Results From the AASK Trial

Wright, J. T. (2002) · JAMA · doi:10.1001/jama.288.19.2421 · Cited by 2,039

Effect of Aerobic Exercise on Blood Pressure: A Meta-Analysis of Randomized, Controlled Trials

Whelton, S. P., Chin, A., Xin, X., & He, J. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-7-200204020-00006 · Cited by 1,970

Statins for the primary prevention of cardiovascular disease

Taylor, F., Huffman, M. D., Macedo, A. F., Moore, T. H., Burke, M., Davey Smith, G., Ward, K., Ebrahim, S., & Gay, H. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004816.pub5 · Cited by 1,934

Prescribing Personalized Nutrition for Cardiovascular Health: Are We Ready?

Juma, S., Imrhan, V., Vijayagopal, P., & Prasad, C. (2014) · Lifestyle Genomics · doi:10.1159/000370213 · Cited by 1,908

Age-specific Incidence Rates of Myocardial Infarction and Angina in Women with Systemic Lupus Erythematosus: Comparison with the Framingham Study

Manzi, S., Meilahn, E. N., Rairie, J. E., Conte, C. G., Medsger, T. A., Jansen-McWilliams, L., D’Agostino, R. B., & Kuller, L. H. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009122 · Cited by 1,831

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): A double-blind, randomised placebo-controlled trial

Hernandez, A. F., Green, J. B., Janmohamed, S., D'Agostino, R. B., Granger, C. B., Jones, N. P., Leiter, L. A., Rosenberg, A. E., Sigmon, K. N., Somerville, M. C., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32261-x · Cited by 1,829

Exercise Training for Blood Pressure: A Systematic Review and Meta‐analysis

Cornelissen, V. A., & Smart, N. A. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.112.004473 · Cited by 1,683

The J-Curve Phenomenon in Hypertension

Kang, Y., & Wang, J. (2016) · Pulse · doi:10.1159/000446922 · Cited by 1,551

Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis

Silverman, M. G., Ference, B. A., Im, K., Wiviott, S. D., Giugliano, R. P., Grundy, S. M., Braunwald, E., & Sabatine, M. S. (2016) · JAMA · doi:10.1001/jama.2016.13985 · Cited by 1,483

Social Determinants of Risk and Outcomes for Cardiovascular Disease: A Scientific Statement From the American Heart Association

Havranek, E. P., Mujahid, M. S., Barr, D. A., Blair, I. V., Cohen, M. S., Cruz-Flores, S., Davey-Smith, G., Dennison-Himmelfarb, C. R., Lauer, M. S., Lockwood, D. W., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000228 · Cited by 1,472

Sedentary behaviour and risk of all-cause, cardiovascular and cancer mortality, and incident type 2 diabetes: a systematic review and dose response meta-analysis

Patterson, R., McNamara, E., Tainio, M., de Sá, T. H., Smith, A. D., Sharp, S. J., Edwards, P., Woodcock, J., Brage, S., & Wijndaele, K. (2018) · European Journal of Epidemiology · doi:10.1007/s10654-018-0380-1 · Cited by 1,423

Socioeconomic Status and Cardiovascular Outcomes: Challenges and Interventions

Schultz, W. M., Kelli, H. M., Lisko, J. C., Varghese, T., Shen, J., Sandesara, P., Quyyumi, A. A., Taylor, H. A., Gulati, M., Harold, J. G., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.029652 · Cited by 1,408

Influence of Weight Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials

Neter, J. E., Stam, B. E., Kok, F. J., Grobbee, D. E., & Geleijnse, J. M. (2003) · Hypertension · doi:10.1161/01.hyp.0000094221.86888.ae · Cited by 1,391

Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials

He, F. J., Li, J., & MacGregor, G. A. (2013) · BMJ · doi:10.1136/bmj.f1325 · Cited by 1,358

Effects of Comprehensive Lifestyle Modification on Blood Pressure Control: Main Results of the PREMIER Clinical Trial

(2003) · JAMA · doi:10.1001/jama.289.16.2083 · Cited by 1,331

Association Between Dietary Factors and Mortality From Heart Disease, Stroke, and Type 2 Diabetes in the United States

Micha, R., Peñalvo, J. L., Cudhea, F., Imamura, F., Rehm, C. D., & Mozaffarian, D. (2017) · JAMA · doi:10.1001/jama.2017.0947 · Cited by 1,316

Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age

Lloyd-Jones, D. M., Leip, E. P., Larson, M. G., D’Agostino, R. B., Beiser, A., Wilson, P. W. F., Wolf, P. A., & Levy, D. (2006) · Circulation · doi:10.1161/circulationaha.105.548206 · Cited by 1,298

Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013.

Kyu, H. H., Bachman, V. F., Alexander, L. T., Mumford, J. E., Afshin, A., Estep, K., Veerman, J. L., Delwiche, K., Iannarone, M. L., Moyer, M. L., et al. (2016) · BMJ · doi:10.1136/bmj.i3857 · Cited by 1,272

Effect of lower sodium intake on health: systematic review and meta-analyses

Aburto, N. J., Ziolkovska, A., Hooper, L., Elliott, P., Cappuccio, F. P., & Meerpohl, J. J. (2013) · BMJ · doi:10.1136/bmj.f1326 · Cited by 1,242

Global Sodium Consumption and Death from Cardiovascular Causes

Mozaffarian, D., Fahimi, S., Singh, G. M., Micha, R., Khatibzadeh, S., Engell, R. E., Lim, S., Danaei, G., Ezzati, M., & Powles, J. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1304127 · Cited by 1,218

Sodium Reduction and Weight Loss in the Treatment of Hypertension in Older Persons: A Randomized Controlled Trial of Nonpharmacologic Interventions in the Elderly (TONE)

Whelton, P. K., Appel, L. J., Espeland, M. A., Applegate, W. B., Ettinger, Jr., Kostis, J. B., Kumanyika, S., Lacy, C. R., Johnson, K. C., Folmar, S., et al. (1998) · JAMA · doi:10.1001/jama.279.11.839 · Cited by 1,200

Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP)

Cook, N. R., Cutler, J. A., Obarzanek, E., Buring, J. E., Rexrode, K. M., Kumanyika, S. K., Appel, L. J., & Whelton, P. K. (2007) · BMJ · doi:10.1136/bmj.39147.604896.55 · Cited by 1,179

Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.

Anthenelli, R. M., Benowitz, N. L., West, R., St Aubin, L., McRae, T., Lawrence, D., Ascher, J., Russ, C., Krishen, A., & Evins, A. E. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30272-0 · Cited by 1,177

Progression of Chronic Kidney Disease: The Role of Blood Pressure Control, Proteinuria, and Angiotensin-Converting Enzyme Inhibition: A Patient-Level Meta-Analysis

Jafar, T. H., Stark, P. C., Schmid, C. H., Landa, M., Maschio, G., de Jong, P. E., de Zeeuw, D., Shahinfar, S., Toto, R. D., Levey, A. S., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-4-200308190-00006 · Cited by 1,149

Preeclampsia and Future Cardiovascular Health: A Systematic Review and Meta-Analysis

Wu, P., Haththotuwa, R., Kwok, C. S., Babu, A., Kotronias, R. A., Rushton, C., Zaman, A., Fryer, A. A., Kadam, U., Chew-Graham, C. A., et al. (2017) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.116.003497 · Cited by 1,147

Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly

McNeil, J. J., Wolfe, R., Woods, R. L., Tonkin, A. M., Donnan, G. A., Nelson, M. R., Reid, C. M., Lockery, J. E., Kirpach, B., Storey, E., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1805819 · Cited by 1,139

Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study

Dehghan, M., Mente, A., Zhang, X., Swaminathan, S., Li, W., Mohan, V., Iqbal, R., Kumar, R., Wentzel-Viljoen, E., Rosengren, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32252-3 · Cited by 1,101

Effects of Oral Potassium on Blood Pressure

Whelton, P. K. (1997) · JAMA · doi:10.1001/jama.1997.03540440058033 · Cited by 1,096

Major Risk Factors as Antecedents of Fatal and Nonfatal Coronary Heart Disease Events

Greenland, P. (2003) · JAMA · doi:10.1001/jama.290.7.891 · Cited by 1,053

Dose Response Between Physical Activity and Risk of Coronary Heart Disease: A Meta-Analysis

Sattelmair, J., Pertman, J., Ding, E. L., Kohl, H. W., Haskell, W., & Lee, I.-M. (2011) · Circulation · doi:10.1161/circulationaha.110.010710 · Cited by 1,052

Healthful and Unhealthful Plant-Based Diets and the Risk of Coronary Heart Disease in U.S. Adults

Satija, A., Bhupathiraju, S. N., Spiegelman, D., Chiuve, S. E., Manson, J. E., Willett, W., Rexrode, K. M., Rimm, E. B., & Hu, F. B. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.05.047 · Cited by 991

Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses

Aburto, N., Hanson, S., Gutiérrez, H., Hooper, L., Elliott, P., & Cappuccio, F. P. (2013) · BMJ · doi:10.1136/bmj.f1378 · Cited by 982

Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis

Xie, X., Atkins, E., Lv, J., Bennett, A., Neal, B., Ninomiya, T., Woodward, M., MacMahon, S., Turnbull, F., Hillis, G. S., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00805-3 · Cited by 980

The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease

Belch, J., MacCuish, A., Campbell, I., Cobbe, S., Taylor, R., Prescott, R., Lee, R., Bancroft, J., MacEwan, S., Shepherd, J., et al. (2008) · BMJ · doi:10.1136/bmj.a1840 · Cited by 977

Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group

Neaton, J. D. (1993) · JAMA · doi:10.1001/jama.270.6.713 · Cited by 949

Added sugar intake and cardiovascular diseases mortality among US adults

Yang, Q., Zhang, Z., Gregg, E. W., Flanders, W. D., Merritt, R., & Hu, F. B. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.13563 · Cited by 947

Lifetime risks of cardiovascular disease

Berry, J. D., Dyer, A., Cai, X., Garside, D. B., Ning, H., Thomas, A., Greenland, P., Van Horn, L., Tracy, R. P., & Lloyd-Jones, D. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1012848 · Cited by 945

Effects of Aerobic and Resistance Training on Hemoglobin A 1c Levels in Patients With Type 2 Diabetes: A Randomized Controlled Trial

Church, T. S., Blair, S. N., Cocreham, S., Johannsen, N., Johnson, W., Kramer, K., Mikus, C. R., Myers, V., Nauta, M., Rodarte, R. Q., et al. (2010) · JAMA · doi:10.1001/jama.2010.1710 · Cited by 944

Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia

Khera, A. V., Won, H.-H., Peloso, G. M., Lawson, K. S., Bartz, T. M., Deng, X., van Leeuwen, E. M., Natarajan, P., Emdin, C. A., Bick, A. G., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.520 · Cited by 942

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C. T., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S. D., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000624 · Cited by 933

Feasibility of Treating Prehypertension with an Angiotensin-Receptor Blocker

Julius, S., Nesbitt, S. D., Egan, B. M., Weber, M. A., Michelson, E. L., Kaciroti, N., Black, H. R., Grimm, R. H., Messerli, F. H., Oparil, S., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060838 · Cited by 927

Predicting the 30-Year Risk of Cardiovascular Disease

Pencina, M. J., D’Agostino, R. B., Larson, M. G., Massaro, J. M., & Vasan, R. S. (2009) · Circulation · doi:10.1161/circulationaha.108.816694 · Cited by 885

Blood Pressure Lowering in Type 2 Diabetes: A Systematic Review and Meta-analysis

Emdin, C. A., Rahimi, K., Neal, B., Callender, T., Perkovic, V., & Patel, A. (2015) · JAMA · doi:10.1001/jama.2014.18574 · Cited by 854

Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease

Yusuf, S., Bosch, J., Dagenais, G., Zhu, J., Xavier, D., Liu, L., Pais, P., López-Jaramillo, P., Leiter, L. A., Dans, A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1600176 · Cited by 848

Combined pharmacotherapy and behavioural interventions for smoking cessation

Stead, L. F., Koilpillai, P., Fanshawe, T. R., & Lancaster, T. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008286.pub3 · Cited by 829

Effects of Different Modes of Exercise Training on Glucose Control and Risk Factors for Complications in Type 2 Diabetic Patients

Snowling, N. J., & Hopkins, W. G. (2006) · Diabetes Care · doi:10.2337/dc06-1317 · Cited by 813

US Pharmacists' Effect as Team Members on Patient Care: Systematic Review and Meta-Analyses

Chisholm-Burns, M. A., Kim Lee, J., Spivey, C. A., Slack, M., Herrier, R. N., Hall-Lipsy, E., Graff Zivin, J., Abraham, I., Palmer, J., Martin, J. R., et al. (2010) · Medical Care · doi:10.1097/mlr.0b013e3181e57962 · Cited by 809

Sedentary Behavior and Cardiovascular Morbidity and Mortality: A Science Advisory From the American Heart Association

Young, D. R., Hivert, M.-F., Alhassan, S., Camhi, S. M., Ferguson, J. F., Katzmarzyk, P. T., Lewis, C. E., Owen, N., Perry, C. K., Siddique, J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000440 · Cited by 791

Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality: A Systematic Review and Network Meta-analysis

Bundy, J. D., Li, C., Stuchlik, P., Bu, X., Kelly, T. N., Mills, K. T., He, H., Chen, J., Whelton, P. K., & He, J. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.1421 · Cited by 783

Effects of Intensive Blood Pressure Lowering on Cardiovascular and Renal Outcomes: A Systematic Review and Meta-Analysis

Lv, J., Neal, B. C., Ehteshami, P., Ninomiya, T., Woodward, M., Rodgers, A., Wang, H., MacMahon, S. W., Turnbull, F., Hillis, G. S., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001293 · Cited by 777

Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes<subtitle>A Randomized Controlled Trial</subtitle>

Ogawa, H. (2008) · JAMA · doi:10.1001/jama.2008.623 · Cited by 776

Dietary carbohydrate intake and mortality: a prospective cohort study and meta-analysis

Seidelmann, S. B., Claggett, B., Cheng, S., Henglin, M., Shah, A., Steffen, L. M., Folsom, A. R., Rimm, E. B., Willett, W. C., & Solomon, S. D. (2018) · The Lancet Public Health · doi:10.1016/s2468-2667(18)30135-x · Cited by 776

The Effects of Nonpharmacologic Interventions on Blood Pressure of Persons With High Normal Levels

Whelton, P. K. (1992) · JAMA · doi:10.1001/jama.1992.03480090061028 · Cited by 768

Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials

Dickinson, H. O., Mason, J. M., Nicolson, D. J., Campbell, F., Beyer, F. R., Cook, J. V., Williams, B., & Ford, G. A. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000199800.72563.26 · Cited by 759

Insomnia and Risk of Cardiovascular Disease

Javaheri, S., & Redline, S. S. (2017) · CHEST Journal · doi:10.1016/j.chest.2017.01.026 · Cited by 757

Effectiveness of physical activity promotion based in primary care: systematic review and meta-analysis of randomised controlled trials

Orrow, G., Kinmonth, A.-L., Sanderson, S., & Sutton, S. (2012) · BMJ · doi:10.1136/bmj.e1389 · Cited by 739

Effects of Alcohol Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials

Xin, X., He, J., Frontini, M. G., Ogden, L. G., Motsamai, O. I., & Whelton, P. K. (2001) · Hypertension · doi:10.1161/hy1101.093424 · Cited by 738

Association of animal and plant protein intake with all-cause and cause-specific mortality.

Song, M., Fung, T. T., Hu, F. B., Willett, W. C., Longo, V. D., Chan, A. T., & Giovannucci, E. L. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.4182 · Cited by 735

Efficacy of statins in familial hypercholesterolaemia: a long term cohort study

Versmissen, J., Oosterveer, D. M., Yazdanpanah, M., Defesche, J. C., Basart, D. C. G., Liem, A. H., Heeringa, J., Witteman, J. C. M., Lansberg, P. J., Kastelein, J. J. P., et al. (2008) · BMJ · doi:10.1136/bmj.a2423 · Cited by 719

Quantifying the association between physical activity and cardiovascular disease and diabetes: a systematic review and meta-analysis

Wahid, A., Manek, N., Nichols, M., Kelly, P., Foster, C., Webster, P., Kaur, A., Friedemann Smith, C., Wilkins, E., Rayner, M., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002495 · Cited by 715

Higher Diet Quality Is Associated with Decreased Risk of All-Cause, Cardiovascular Disease, and Cancer Mortality among Older Adults

Reedy, J., Krebs‐Smith, S. M., Miller, P. E., Liese, A. D., Kahle, L., Park, Y., & Subar, A. F. (2014) · Journal of Nutrition · doi:10.3945/jn.113.189407 · Cited by 711

10-Year Coronary Heart Disease Risk Prediction Using Coronary Artery Calcium and Traditional Risk Factors

McClelland, R. L., Jorgensen, N. W., Budoff, M. J., Blaha, M. J., Post, W. S., Kronmal, R. A., Bild, D. E., Shea, S., Liu, K., Watson, K. E., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.08.035 · Cited by 685

Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the Multi-Ethnic Study of Atherosclerosis (MESA)

Budoff, M. J., Young, R., Burke, G., Jeffrey Carr, J., Detrano, R. C., Folsom, A. R., Kronmal, R., Lima, J. A. C., Liu, K. J., McClelland, R. L., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy217 · Cited by 684

Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes: A Systematic Review and Meta-analysis

Maruthur, N. M., Tseng, E., Hutfless, S., Wilson, L. M., Suarez-Cuervo, C., Berger, Z., Chu, Y., Iyoha, E., Segal, J. B., & Bolen, S. (2016) · Annals of Internal Medicine · doi:10.7326/m15-2650 · Cited by 682

Treatment of Mild Hypertension Study

Neaton, J. D. (1993) · JAMA · doi:10.1001/jama.1993.03510060059034 · Cited by 669

A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk

Sniderman, A. D., Williams, K., Contois, J. H., Monroe, H. M., McQueen, M. J., de Graaf, J., & Furberg, C. D. (2011) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.110.959247 · Cited by 659

Randomised controlled trial of general practitioner intervention in patients with excessive alcohol consumption

Wallace, P., Cutler, S., & Haines, A. (1988) · BMJ · doi:10.1136/bmj.297.6649.663 · Cited by 648

Effects of Weight Loss and Sodium Reduction Intervention on Blood Pressure and Hypertension Incidence in Overweight People With High-Normal Blood Pressure: The Trials of Hypertension Prevention, Phase II

(1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440270105009 · Cited by 646

Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial

Ruggenenti, P. L., Perna, A., Loriga, G., Ganeva, M. G., Ene‐Iordache, B., Turturro, M., Lesti, M., Perticucci, E., Chakarski, I. N., Leonardis, D., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71082-5 · Cited by 640

Health Literacy and Cardiovascular Disease: Fundamental Relevance to Primary and Secondary Prevention: A Scientific Statement From the American Heart Association

Magnani, J. W., Mujahid, M. S., Aronow, H. D., Cené, C. W., Dickson, V. V., Havranek, E. P., Morgenstern, L. B., Paasche‐Orlow, M. K., Pollak, A. W., & Willey, J. Z. (2018) · Circulation · doi:10.1161/cir.0000000000000579 · Cited by 626

Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease

Lonn, E., Bosch, J., López-Jaramillo, P. A., Zhu, J., Liu, L., Pais, P. S., Díaz, R., Xavier, D., Sliwa, K. S., Dans, A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1600175 · Cited by 626

Aspirin for Prevention of Cardiovascular Events in a General Population Screened for a Low Ankle Brachial Index<subtitle>A Randomized Controlled Trial</subtitle>

Fowkes, F. G. R. (2010) · JAMA · doi:10.1001/jama.2010.221 · Cited by 624

Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data

(2014) · The Lancet · doi:10.1016/s0140-6736(14)61212-5 · Cited by 623

CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.

Johnson, N. B., Hayes, L., Brown, K., Hoo, E., & Ethier, K. A. (2014) · PubMed · Cited by 578

Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium

Mons, U., Müezzinler, A., Gellert, C., Schöttker, B., Abnet, C. C., Bobák, M., de Groot, C. P. G. M., Freedman, N. D., Jansen, E. H. J. M., Kee, F., et al. (2015) · BMJ · doi:10.1136/bmj.h1551 · Cited by 574

Major Dietary Protein Sources and Risk of Coronary Heart Disease in Women

Bernstein, A. M., Sun, Q., Hu, F. B., Stampfer, M. J., Manson, J. E., & Willett, W. C. (2010) · Circulation · doi:10.1161/circulationaha.109.915165 · Cited by 573

The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis

Roerecke, M., Kaczorowski, J., Tobe, S. W., Gmel, G., Hasan, O. S. M., & Rehm, J. (2017) · The Lancet Public Health · doi:10.1016/s2468-2667(17)30003-8 · Cited by 552

Atherosclerotic Cardiovascular Disease in South Asians in the United States: Epidemiology, Risk Factors, and Treatments: A Scientific Statement From the American Heart Association

Volgman, A. S., Palaniappan, L. S., Aggarwal, N. T., Gupta, M., Khandelwal, A., Krishnan, A. V., Lichtman, J. H., Mehta, L. S., Patel, H. N., Shah, K. S., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000580 · Cited by 552

Efficacy and Safety of Atorvastatin in the Prevention of Cardiovascular End Points in Subjects With Type 2 Diabetes

Knopp, R. H., d’Emden, M., Smilde, J. G., Pocock, S. J., & on behalf of the ASPEN Study Group (2006) · Diabetes Care · doi:10.2337/dc05-2415 · Cited by 550

Value of Primordial and Primary Prevention for Cardiovascular Disease: A Policy Statement From the American Heart Association

Weintraub, W. S., Daniels, S. R., Burke, L. E., Franklin, B. A., Goff, D. C., Hayman, L. L., Lloyd-Jones, D., Pandey, D. K., Sanchez, E. J., Schram, A. P., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182285a81 · Cited by 541

An Analysis of Calibration and Discrimination Among Multiple Cardiovascular Risk Scores in a Modern Multiethnic Cohort

DeFilippis, A. P., Young, R. L., Carrubba, C. J., McEvoy, J. W., Budoff, M. J., Blumenthal, R. S., Kronmal, R. A., McClelland, R. L., Nasir, K., & Blaha, M. J. (2015) · Annals of Internal Medicine · doi:10.7326/m14-1281 · Cited by 534

Systematic review and meta-analysis of randomised controlled trials of psychological interventions to improve glycaemic control in patients with type 2 diabetes

Ismail, K., Winkley, K., & Rabe-Hesketh, S. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16202-8 · Cited by 531

ACC/AHA Statement on Cost/Value Methodology in Clinical Practice Guidelines and Performance Measures

Anderson, J. L., Heidenreich, P. A., Barnett, P. G., Creager, M. A., Fonarow, G. C., Gibbons, R. J., Halperin, J. L., Hlatky, M. A., Jacobs, A. K., Mark, D. B., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000042 · Cited by 521

Evaluating the evidence for models of life course socioeconomic factors and cardiovascular outcomes: a systematic review

Pollitt, R. A., Rose, K. M., & Kaufman, J. S. (2005) · BMC Public Health · doi:10.1186/1471-2458-5-7 · Cited by 518

Impact of Lipids on Cardiovascular Health

Ference, B. A., Graham, I., Tokgozoglu, L., & Catapano, A. L. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.06.046 · Cited by 511

Implications of Coronary Artery Calcium Testing Among Statin Candidates According to American College of Cardiology/American Heart Association Cholesterol Management Guidelines

Nasir, K., Bittencourt, M. S., Blaha, M. J., Blankstein, R., Agatson, A. S., Rivera, J. J., Miedema, M. D., Sibley, C. T., Shaw, L. J., Blumenthal, R. S., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.07.066 · Cited by 488

Role of Coronary Artery Calcium Score of Zero and Other Negative Risk Markers for Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis (MESA)

Blaha, M. J., Cainzos-Achirica, M., Greenland, P., McEvoy, J. W., Blankstein, R., Budoff, M. J., Dardari, Z., Sibley, C. T., Burke, G. L., Kronmal, R. A., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.018524 · Cited by 485

Body mass index, waist circumference and waist–hip ratio: which is the better discriminator of cardiovascular disease mortality risk? Evidence from an individual‐participant meta‐analysis of 82 864 participants from nine cohort studies

Czernichow, S., Kengne, A. P., Stamatakis, E., Hamer, M., & Batty, G. D. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00879.x · Cited by 470

Association of changes in diet quality with total and cause-specific mortality

Sotos-Prieto, M., Bhupathiraju, S. N., Mattei, J., Fung, T. T., Li, Y., Pan, A., Willett, W. C., Rimm, E. B., & Hu, F. B. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1613502 · Cited by 466

Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis

Ma, C., Avenell, A., Bolland, M., Hudson, J., Stewart, F., Robertson, C., Sharma, P., Fraser, C., & MacLennan, G. (2017) · BMJ · doi:10.1136/bmj.j4849 · Cited by 464

Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force

LeBlanc, E. S., Patnode, C. D., Webber, E. M., Redmond, N., Rushkin, M., & O’Connor, E. A. (2018) · JAMA · doi:10.1001/jama.2018.7777 · Cited by 463

Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials

Geleijnse, J. M., Kok, F. J., & Grobbee, D. E. (2003) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001575 · Cited by 450

ACC/AHA Statement on Cost/Value Methodology in Clinical Practice Guidelines and Performance Measures

Anderson, J. L., Heidenreich, P. A., Barnett, P. G., Creager, M. A., Fonarow, G. C., Gibbons, R. J., Halperin, J. L., Hlatky, M. A., Jacobs, A. K., Mark, D. B., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.016 · Cited by 447

Association of Specific Dietary Fats With Total and Cause-Specific Mortality

Wang, D. D., Li, Y., Chiuve, S. E., Stampfer, M. J., Manson, J. E., Rimm, E. B., Willett, W. C., & Hu, F. B. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.2417 · Cited by 439

Walking and primary prevention: a meta-analysis of prospective cohort studies

Hamer, M., & Chida, Y. (2007) · British Journal of Sports Medicine · doi:10.1136/bjsm.2007.039974 · Cited by 419

Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes

Griffin, S. J., Leaver, J. K., & Irving, G. J. (2017) · Diabetologia · doi:10.1007/s00125-017-4337-9 · Cited by 398

High Risk of Cardiovascular Disease in Patients With Type 1 Diabetes in the U.K.

Soedamah‐Muthu, S. S., Fuller, J., Mulnier, H. E., Raleigh, V. S., Lawrenson, R. A., & Colhoun, H. M. (2006) · Diabetes Care · doi:10.2337/diacare.29.04.06.dc05-1433 · Cited by 395

2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment

Barua, R. S., Rigotti, N. A., Benowitz, N. L., Cummings, K. M., Jazayeri, M., Morris, P. B., Ratchford, E. V., Sarna, L., Stecker, E. C., & Wiggins, B. S. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.10.027 · Cited by 391

Reduction in Cardiovascular Events With Atorvastatin in 2,532 Patients With Type 2 Diabetes

Sever, P. S., Poulter, N. R., Dahlöf, B., Wedel, H., Collins, R., Beevers, G., Caulfield, M., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., et al. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1151 · Cited by 390

Relationship of Sedentary Behavior and Physical Activity to Incident Cardiovascular Disease

Chomistek, A. K., Manson, J. E., Stefanick, M. L., Lu, B., Sands-Lincoln, M., Going, S. B., Garcia, L., Allison, M. A., Sims, S. T., LaMonte, M. J., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.03.031 · Cited by 389

Behavioral Counseling to Promote a Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Known Cardiovascular Disease Risk Factors: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force

Patnode, C. D., Evans, C. V., Senger, C. A., Redmond, N., & Lin, J. S. (2017) · JAMA · doi:10.1001/jama.2017.3303 · Cited by 380

Association of Nut Consumption with Total and Cause-Specific Mortality

Bao, Y., Han, J., Hu, F. B., Giovannucci, E. L., Stampfer, M. J., Willett, W. C., & Fuchs, C. S. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1307352 · Cited by 367

Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease

Hong, J., Zhang, Y., Lai, S., Lv, A., Su, Q., Dong, Y., Zhou, Z., Tang, W., Zhao, J., Cui, L., et al. (2013) · Diabetes Care · doi:10.2337/dc12-0719 · Cited by 366

Association of Coronary Artery Calcium in Adults Aged 32 to 46 Years With Incident Coronary Heart Disease and Death

Carr, J. J., Jacobs, D. R., Terry, J. G., Shay, C. M., Sidney, S., Liu, K., Schreiner, P. J., Lewis, C. E., Shikany, J. M., Reis, J. P., et al. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2016.5493 · Cited by 361

The Potency of Team-Based Care Interventions for Hypertension

Carter, B. L., Rogers, M., Daly, J. M., Zheng, S., & James, P. A. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.316 · Cited by 354

Psychosocial factors in medication adherence and diabetes self-management: Implications for research and practice.

Gonzalez, J. S., Tanenbaum, M. L., & Commissariat, P. V. (2016) · American Psychologist · doi:10.1037/a0040388 · Cited by 354

Isometric Exercise Training for Blood Pressure Management: A Systematic Review and Meta-analysis

Carlson, D. J., Dieberg, G., Hess, N., Millar, P. J., & Smart, N. A. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.10.030 · Cited by 353

Relation of Smoking With Total Mortality and Cardiovascular Events Among Patients With Diabetes Mellitus: A Meta-Analysis and Systematic Review

Pan, A., Wang, Y., Talaei, M., & Hu, F. B. (2015) · Circulation · doi:10.1161/circulationaha.115.017926 · Cited by 343

Systematic Review: Blood Pressure Target in Chronic Kidney Disease and Proteinuria as an Effect Modifier

Upadhyay, A., Earley, A., Haynes, S. M., & Uhlig, K. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-8-201104190-00335 · Cited by 338

Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials

(2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30156-5 · Cited by 338

Statins for the primary prevention of cardiovascular disease

Ebrahim, S. B. J., Taylor, F. C., & Brindle, P. (2014) · BMJ · doi:10.1136/bmj.g280 · Cited by 335

Early menopause predicts future coronary heart disease and stroke

Wellons, M., Ouyang, P., Schreiner, P. J., Herrington, D. M., & Vaidya, D. M. (2012) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3182517bd0 · Cited by 320

Effects of Low-Sodium Diet vs. High-Sodium Diet on Blood Pressure, Renin, Aldosterone, Catecholamines, Cholesterol, and Triglyceride (Cochrane Review)

Graudal, N. A., Hubeck‐Graudal, T., & Jűrgens, G. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2011.210 · Cited by 314

Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis

Lv, J., Ehteshami, P., Sarnak, M. J., Tighiouart, H., Jun, M., Ninomiya, T., Foote, C., Rodgers, A., Zhang, H., Wang, H., et al. (2013) · Canadian Medical Association Journal · doi:10.1503/cmaj.121468 · Cited by 309

A provegetarian food pattern and reduction in total mortality in the Prevencion con Dieta Mediterranea (PREDIMED) study

Martínez-González, M. A., Sánchez-Tainta, A., Corella, D., Salas-Salvadó, J., Ros, E., Arós, F., Gómez-Gracia, E., Fiol, M., Lamuela-Raventós, R. M., Schröder, H., et al. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.071431 · Cited by 309

Effects of the Dietary Approaches to Stop Hypertension (DASH) Eating Plan on Cardiovascular Risks Among Type 2 Diabetic Patients

Azadbakht, L., Fard, N. R. P., Karimi, M., Baghaei, M. H., Surkan, P. J., Rahimi, M., Esmaillzadeh, A., & Willett, W. C. (2011) · Diabetes Care · doi:10.2337/dc10-0676 · Cited by 304

Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Japanese Patients 60 Years or Older With Atherosclerotic Risk Factors: A Randomized Clinical Trial

Ikeda, Y., Shimada, K., Teramoto, T., Uchiyama, S., Yamazaki, T., Oikawa, S., Sugawara, M., Ando, K., Murata, M., Yokoyama, K., et al. (2014) · JAMA · doi:10.1001/jama.2014.15690 · Cited by 301

Comparative Effectiveness of Implementation Strategies for Blood Pressure Control in Hypertensive Patients: A Systematic Review and Meta-analysis

Mills, K. T., Obst, K. M., Shen, W., Molina, S., Zhang, H.-J., He, H., Cooper, L. A., & He, J. (2018) · Annals of Internal Medicine · doi:10.7326/m17-1805 · Cited by 299

Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels – updated overview and meta-analyses of randomized trials

Thomopoulos, C., Parati, G., & Zanchetti, A. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000000881 · Cited by 298

Effects of Mediterranean-style diet on glycemic control, weight loss and cardiovascular risk factors among type 2 diabetes individuals: A meta-analysis

Huo, R., Du, T., Xu, Y., Xu, W., Chen, X., Sun, K., & Yu, X. (2015) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2014.243 · Cited by 296

Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System

Halperin, J. L., Levine, G. N., Al‐Khatib, S. M., Birtcher, K. K., Bozkurt, B., Brindis, R. G., Cigarroa, J. E., Curtis, L. H., Fleisher, L. A., Gentile, F., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000312 · Cited by 295

Lifetime Risk and Years Lived Free of Total Cardiovascular Disease

Wilkins, J. T., Ning, H., Berry, J. D., Zhao, L., Dyer, A. R., & Lloyd‐Jones, D. M. (2012) · JAMA · doi:10.1001/jama.2012.14312 · Cited by 293

Training health professionals in smoking cessation

Carson‐Chahhoud, K., Verbiest, M. E. A., Crone, M. R., Brinn, M. P., Esterman, A. J., Assendelft, W. J., & Smith, B. J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000214.pub2 · Cited by 290

Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes

Micha, R., & Mozaffarian, D. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.79 · Cited by 290

Cost-Effectiveness of Intensive versus Standard Blood-Pressure Control

Bress, A. P., Bellows, B. K., King, J. B., Hess, R., Beddhu, S., Zhang, Z., Berlowitz, D. R., Conroy, M. B., Fine, L. J., Oparil, S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmsa1616035 · Cited by 289

Team-Based Care and Improved Blood Pressure Control

Proia, K. K., Thota, A. B., Njie, G. J., Finnie, R. K. C., Hopkins, D. P., Mukhtar, Q., Pronk, N. P., Zeigler, D. W., Kottke, T. E., Rask, K. J., et al. (2014) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2014.03.004 · Cited by 286

Discrimination and Net Reclassification of Cardiovascular Risk With Lipoprotein(a)

Willeit, P., Kiechl, S., Kronenberg, F., Witztum, J. L., Santer, P., Mayr, M., Xu, Q., Mayr, A., Willeit, J., & Tsimikas, S. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.061 · Cited by 286

Heart Disease and Cancer Deaths — Trends and Projections in the United States, 1969–2020

Weir, H. K., Anderson, R. N., King, S. M. C., Soman, A. V., Thompson, T., Hong, Y., Møller, B., & Leadbetter, S. (2016) · Preventing Chronic Disease · doi:10.5888/pcd13.160211 · Cited by 276

Sex differences in the relationship between socioeconomic status and cardiovascular disease: a systematic review and meta-analysis

Backholer, K., Peters, S. A. E., Bots, S. H., Peeters, A., Huxley, R., & Woodward, M. (2016) · Journal of Epidemiology & Community Health · doi:10.1136/jech-2016-207890 · Cited by 271

Utility of Nontraditional Risk Markers in Atherosclerotic Cardiovascular Disease Risk Assessment

Yeboah, J., Young, R. L., McClelland, R. L., Delaney, J. A., Polonsky, T. S., Dawood, F. Z., Blaha, M. J., Miedema, M. D., Sibley, C. T., Carr, J. J., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.10.058 · Cited by 270

Isometric exercise training for blood pressure management: a systematic review and meta-analysis to optimize benefit

Inder, J. D., Carlson, D. J., Dieberg, G., McFarlane, J. R., Hess, N. C., & Smart, N. A. (2016) · Hypertension Research · doi:10.1038/hr.2015.111 · Cited by 268

A 15-Year Warranty Period for Asymptomatic Individuals Without Coronary Artery Calcium

Valenti, V., Hartaigh, B. Ó., Heo, R., Cho, I., Schulman‐Marcus, J., Gransar, H., Truong, Q. A., Shaw, L. J., Knapper, J. T., Kelkar, A. A., et al. (2015) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2015.01.025 · Cited by 267

Built Environment, Selected Risk Factors and Major Cardiovascular Disease Outcomes: A Systematic Review

Malambo, P., Kengne, A. P., de Villiers, A., Lambert, E. V., & Puoane, T. R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166846 · Cited by 265

Aspirin for the Primary Prevention of Cardiovascular Events: A Systematic Evidence Review for the U.S. Preventive Services Task Force

Guirguis‐Blake, J., Evans, C. V., Senger, C. A., O’Connor, E., & Whitlock, E. P. (2016) · Annals of Internal Medicine · doi:10.7326/m15-2113 · Cited by 264

Effects of Blood Pressure Reduction in Mild Hypertension

Sundström, J., Arima, H., Jackson, R., Turnbull, F., Rahimi, K., Chalmers, J. P., Woodward, M., & Neal, B. C. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0773 · Cited by 261

Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial

Margolis, K. L., O’Connor, P. J., Morgan, T. M., Buse, J. B., Cohen, R. M., Cushman, W. C., Cutler, J. A., Evans, G. W., Gerstein, H. C., Grimm, R. H., et al. (2014) · Diabetes Care · doi:10.2337/dc13-2334 · Cited by 259

A Systematic Review of the Prevalence and Outcomes of Ideal Cardiovascular Health in US and Non-US Populations

Younus, A., Aneni, E. C., Spatz, E. S., Osondu, C. U., Roberson, L., Ogunmoroti, O., Malik, R., Ali, S. S., Aziz, M., Feldman, T., et al. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.01.019 · Cited by 252

Participatory Decision Making, Patient Activation, Medication Adherence, and Intermediate Clinical Outcomes in Type 2 Diabetes: A STARNet Study

Parchman, M. L., Zeber, J. E., & Palmer, R. F. (2010) · The Annals of Family Medicine · doi:10.1370/afm.1161 · Cited by 251

The Past, Present, and Future of Nicotine Addiction Therapy

Prochaska, J. J., & Benowitz, N. L. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-111314-033712 · Cited by 245

Cost-Effectiveness of Hypertension Therapy According to 2014 Guidelines

Moran, A. E., Odden, M. C., Thanataveerat, A., Tzong, K. Y., Rasmussen, P. W., Guzman, D., Williams, L. W., Bibbins-Domingo, K. B., Coxson, P. G., & Goldman, L. (2015) · New England Journal of Medicine · doi:10.1056/nejmsa1406751 · Cited by 244

Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study

Huo, X., Gao, L., Guo, L., Xu, W., Wang, W., Zhi, X., Li, L., Ren, Y., Qi, X., Sun, Z., et al. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00508-2 · Cited by 241

Low-Carbohydrate Diets and All-Cause Mortality: A Systematic Review and Meta-Analysis of Observational Studies

Noto, H., Goto, A., Tsujimoto, T., & Noda, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055030 · Cited by 240

A Randomized Trial of the Effect of Community Pharmacist and Nurse Care on Improving Blood Pressure Management in Patients With Diabetes Mellitus

McLean, D. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.21.2355 · Cited by 239

Behavioral counseling and pharmacotherapy interventions for tobacco cessation in adults, including pregnant women: a review of reviews for the U.S. Preventive Services Task Force.

Patnode, C. D., Henderson, J. T., Thompson, J. H., Senger, C. A., Fortmann, S. P., & Whitlock, E. P. (2015) · Annals of Internal Medicine · doi:10.7326/m15-0171 · Cited by 238

Cardiovascular Risk Prediction Functions Underestimate Risk in HIV Infection

Triant, V. A., Perez, J., Regan, S., Massaro, J. M., Meigs, J. B., Grinspoon, S. K., & D’Agostino, R. B. (2018) · Circulation · doi:10.1161/circulationaha.117.028975 · Cited by 237

Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the U.S. Preventive Services Task Force

Whitlock, E. P., Burda, B. U., Williams, S. B., Guirguis‐Blake, J., & Evans, C. V. (2016) · Annals of Internal Medicine · doi:10.7326/m15-2112 · Cited by 232

Sociodemographic and cultural determinants of sleep deficiency: implications for cardiometabolic disease risk

Knutson, K. L. (2013) · Social Science & Medicine · doi:10.1016/j.socscimed.2012.05.002 · Cited by 228

Mortality in the United States, 1900-1950

Gordon, T. (1953) · Public Health Reports (1896-1970) · doi:10.2307/4588443 · Cited by 222

Percent reduction in LDL cholesterol following high-intensity statin therapy: potential implications for guidelines and for the prescription of emerging lipid-lowering agents

Ridker, P. M., Mora, S., & Rose, L. M. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw046 · Cited by 222

Antihypertensive Treatment and Secondary Prevention of Cardiovascular Disease Events Among Persons Without Hypertension

Thompson, A. M. (2011) · JAMA · doi:10.1001/jama.2011.250 · Cited by 219

Coronary Artery Calcium Score for Long-term Risk Classification in Individuals With Type 2 Diabetes and Metabolic Syndrome From the Multi-Ethnic Study of Atherosclerosis

Malik, S., Zhao, Y., Budoff, M., Nasir, K., Blumenthal, R. S., Bertoni, A. G., & Wong, N. D. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.4191 · Cited by 215

The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials

Czernichow, S., Zanchetti, A., Turnbull, F., Barzi, F., Ninomiya, T., Kengne, A. P., Heerspink, H. J. L., Perkovic, V., Huxley, R., Arima, H., et al. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834000be · Cited by 208

A Randomized Trial to Improve Patient-Centered Care and Hypertension Control in Underserved Primary Care Patients

Cooper, L. A., ROTER, D. L., Carson, K. A., Bone, L., Larson, S. M., Miller, E. R., Barr, M. S., & Levine, D. M. (2011) · Journal of General Internal Medicine · doi:10.1007/s11606-011-1794-6 · Cited by 202

Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies

Rodríguez, L. A. G., Martín‐Pérez, M., Hennekens, C. H., Rothwell, P. M., & Lanas, Á. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160046 · Cited by 201

Effects of education and income on cardiovascular outcomes: A systematic review and meta-analysis

Khaing, W., Vallibhakara, S. A.-O., Attia, J., McEvoy, M., & Thakkinstian, A. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487317705916 · Cited by 200

Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia Phenotype

Perak, A. M., Ning, H., de Ferranti, S. D., Gooding, H. C., Wilkins, J. T., & Lloyd‐Jones, D. M. (2016) · Circulation · doi:10.1161/circulationaha.116.022335 · Cited by 197

Healthy Plant-Based Diets Are Associated with Lower Risk of All-Cause Mortality in US Adults

Kim, H., Caulfield, L. E., & Rebholz, C. M. (2018) · Journal of Nutrition · doi:10.1093/jn/nxy019 · Cited by 196

Preterm Delivery and Maternal Cardiovascular Disease in Young and Middle-Aged Adult Women

Tanz, L. J., Stuart, J. J., Williams, P. L., Rimm, E. B., Missmer, S. A., Rexrode, K. M., Mukamal, K. J., & Rich-Edwards, J. W. (2017) · Circulation · doi:10.1161/circulationaha.116.025954 · Cited by 194

Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System

Halperin, J. L., Levine, G. N., Al-Khatib, S. M., Birtcher, K. K., Bozkurt, B., Brindis, R. G., Cigarroa, J. E., Curtis, L. H., Fleisher, L. A., Gentile, F., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.09.001 · Cited by 191

Effectiveness of physical activity promotion interventions in primary care: A review of reviews

Sánchez, Á., Bully, P., Martinez, C., & Gonzalo Grandes, O. (2014) · Preventive Medicine · doi:10.1016/j.ypmed.2014.09.012 · Cited by 189

Low-carbohydrate–high-protein diet and long-term survival in a general population cohort

Trichopoulou, A., Ψαλτοπούλου, Θ., Orfanos, P., Hsieh, C.-C., & Trichopoulos, D. (2006) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602557 · Cited by 187

Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta-Analysis of Randomized Trials

Bangalore, S., Toklu, B., Gianos, E., Schwartzbard, A. Z., WEINTRAUB, H. S., Ogedegbe, G. G., & Messerli, F. H. (2017) · The American Journal of Medicine · doi:10.1016/j.amjmed.2017.01.004 · Cited by 184

The Identification of Calcified Coronary Plaque Is Associated With Initiation and Continuation of Pharmacological and Lifestyle Preventive Therapies

Gupta, A., Lau, E., Varshney, R., Hulten, E. A., Cheezum, M., Bittencourt, M. S., Blaha, M. J., Wong, N. D., Blumenthal, R. S., Budoff, M. J., et al. (2017) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2017.01.030 · Cited by 181

The Severe Hypercholesterolemia Phenotype

Sniderman, A. D., Tsimikas, S., & Fazio, S. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.01.060 · Cited by 180

Body mass index, waist circumference, and risk of coronary heart disease: A prospective study among men and women

Flint, A. J., Rexrode, K. M., Hu, F. B., Glynn, R. J., Caspard, H., Manson, J. E., Willett, W. C., & Rimm, E. B. (2010) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2010.01.001 · Cited by 179

Statins in Familial Hypercholesterolemia

Besseling, J., Hovingh, G. K., Huijgen, R., Kastelein, J. J. P., & Hutten, B. A. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.04.054 · Cited by 178

Low-Calorie Sweetened Beverages and Cardiometabolic Health: A Science Advisory From the American Heart Association

Johnson, R. K., Lichtenstein, A. H., Anderson, C. A. M., Carson, J. A., Després, J.-P., Hu, F. B., Kris-Etherton, P. M., Otten, J. J., Towfighi, A., Wylie-Rosett, J., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000569 · Cited by 176

A Randomized Controlled Trial of Team-Based Care: Impact of Physician-Pharmacist Collaboration on Uncontrolled Hypertension

Hunt, J. S., Siemienczuk, J., Pape, G., Rozenfeld, Y., Mackay, J., LeBlanc, B., & Touchette, D. R. (2008) · Journal of General Internal Medicine · doi:10.1007/s11606-008-0791-x · Cited by 171

2020 International Society of Hypertension Global Hypertension Practice Guidelines

Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15026 · Cited by 4,132

The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030

Vogel, B., Mónica Acevedo, B., Appelman, Y., Merz, C. N. B., Chieffo, A., Figtree, G. A., Guerrero, M. E., Kunadian, V., Lam, C. S. P., Maas, A. H. E. M., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00684-x · Cited by 1,587

2020 International Society of Hypertension global hypertension practice guidelines

Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002453 · Cited by 1,283

KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease

Cheung, A. K., Chang, T. I., Cushman, W. C., Furth, S. L., Hou, F. F., Ix, J. H., Knoll, G. A., Muntner, P., Pecoits-Filho, R., Sarnak, M. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2020.11.003 · Cited by 1,452

Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023

Stark, B. A., DeCleene, N. K., Desai, E. C., Hsu, J. M., Johnson, C. O., Lara-Castor, L., LeGrand, K. E., Prof Bhoomadevi, A., Aalipour, M. A., Aalruz, H., et al. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.08.015 · Cited by 900

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease

Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.010 · Cited by 1,896

Addendum to: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary

(2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.015 · Cited by 1

Addendum to: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease

(2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.016 · Cited by 1

2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000678 · Cited by 4,536

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Part 1, Lifestyle and Behavioral Factors

Arnett, D. K., Khera, A., & Blumenthal, R. S. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.2604 · Cited by 182